Analystreport

Castle Biosciences, Inc. (NASDAQ: CSTL) is now covered by analysts at Stephens. They set an "overweight" rating and a $59.00 price target on the stock.

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report